维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Enseleit F"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Darusentan:a new perspective for treatment of resistant hypertension显示文摘	Enseleit F Luscher TF Ruschitzka F	2008	Expert Opin Investig Drugs2008，17，8：	1
2	Hemodynamic and neurohumoraleffects of selective endothelin A (ET(A)) receptor blockade in chronic heartfailure:the Heart Failure ET(A) Receptor Blockade Trial (HEAT) 显示文摘	Luscher TF Enseleit F Pacher R	2002	Cir-culation2002，106，21：	1
3	Concep- tions, materials, processing technologies and fields of application for miniaturized electrochemical sensors with planar membranes 显示文摘	Vonan W Enseleit U Gerlach F etal	2004	Electrochim Acta2004，49，：	1
4	Cholesteryl ester transfer protein inhibition and endothelial function in type Ⅱ hyperlipidemia显示文摘	Hermann F Enseleit F Spieker LE	2009	Thromb Res2009，123，3：	1
5	Effects of long-term selsctive ETA receptor blockade on neunhumoral activation in congestive heart failure显示文摘	Hurlimann D Ruschitzka F Enseleit F	2001	Eur Heart J2001，22，1：	1
6	Isolated cleft in the posterior mitral valve leaflet:A congenital form of mitral regurgitation显示文摘	Wyss CA Enseleit F van der Loo B		0，，：	1
7	Endothelin antagonists and heart failure显示文摘	Enseleit F Noll G	2002	Curt Hypertens Reports2002，4，1：	1
8	Endothelin antagonists and heart failure显示文摘	Hürlimann D Enseleit F Noll G	2002	Curr Hypertens Rep2002，4，1：	1
9	Hemodynamic and neurohumoraleffects of selective endothelin A(ETA) receptor blockade in chronic heart fail-ure:the heart failure ETA receptor blockade trial(HEAT)显示文摘	Luscher TF Enseleit F Pacher R	2002	Circulation2002，106，21：	1
10	Hemodynamic and neurohumoral effects of selective endothelin A (ET(A) ) receptor blockade in chronic heart failure: the Heart Failure ET (A) Receptor Blockade Trial (HEAT) 显示文摘	Luscher TF Enseleit F Pacher R	2002	Circulation2002，106，21：	1
11	Anti-vegf therapies and blood pressure: more than meets the eye显示文摘	Enseleit F Michels S Ruschitzka F	2010	Curr Hypertens Rep2010，12，：	1
12	Folic acid improves baroreceptor sensitivity in hypertension 显示文摘	Bechir M Enseleit F Chenevard R	2005	Jcardiovasc Pharmacol2005，45，1：	1
13	Angiotensin-eonverting enzyme inhibition and endothelial dysfunction:focus on ramipril显示文摘	Enseleit F Luseher TF Rusehitzka F	2003	Eur Heart J2003，，：	1
14	Cyclosporine C0-versus C2-monitoring over three years in maintenance heart transplantation 显示文摘	Hermann M Enseleit F Fisler A E	2011	Swiss Med Wkly2011，141，13：	1
15	Folic acid improves baroreceptor sensitivity in hypertension 显示文摘	Bechir M Enseleit F Chenevard R	2005	J Cardiovasc Pharmacol2005，45，1：	1
16	Statins and the risk of cancer after heart transplantation显示文摘	Frohlich GM Rufibach K Enseleit F		0，，：	1
17	Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling显示文摘	Frohlich G Steffel 1 Htir limann D Enseleit F Luscher T F Ruschitzka F	2010	Eur Heart 12010，31，：	1
18	Endothelin antagonists and heart failure显示文摘	Hurlimann D Enseleit F Noll G	2002	Curr Hypertens Reports2002，4，1：	1
19	Darusentan: a new perspective for treatment of resistant hypertension 显示文摘	Enseleit F Luscher TF Ruschitzka F	2008	Expert Opin InVestig Drugs2008，17，8：	1
20	Endothelin antagonists and heart failure 显示文摘	Htlrlimann D Enseleit F Nol! G	2002	Curt Hypertens Rep2002，4，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示